"beta-Lactams" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria.
Descriptor ID |
D047090
|
MeSH Number(s) |
D02.065.589.099 D02.886.108 D03.633.100.300
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "beta-Lactams".
Below are MeSH descriptors whose meaning is more specific than "beta-Lactams".
This graph shows the total number of publications written about "beta-Lactams" by people in this website by year, and whether "beta-Lactams" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 1 | 1 |
2007 | 2 | 2 | 4 |
2008 | 0 | 1 | 1 |
2010 | 1 | 0 | 1 |
2011 | 0 | 1 | 1 |
2012 | 1 | 1 | 2 |
2013 | 1 | 1 | 2 |
2017 | 20 | 19 | 39 |
2018 | 17 | 11 | 28 |
2019 | 10 | 7 | 17 |
2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "beta-Lactams" by people in Profiles.
-
Optimizing preoperative antibiotics in patients with ß-lactam allergies: A role for pharmacy. Am J Health Syst Pharm. 2021 Aug 30; 78(Supplement_3):S76-S82.
-
The urgent need for metallo-ß-lactamase inhibitors: an unattended global threat. Lancet Infect Dis. 2022 01; 22(1):e28-e34.
-
Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainment. Medicine (Baltimore). 2021 Jun 04; 100(22):e26253.
-
Mass spectrometry reveals potential of ß-lactams as SARS-CoV-2 Mpro inhibitors. Chem Commun (Camb). 2021 Feb 15; 57(12):1430-1433.
-
Risk factors for bronchiolitis and asthma, and COVID-19 symptoms in young children. Pediatr Allergy Immunol. 2021 02; 32(2):215-218.
-
Preliminary therapeutic drug monitoring data of ß-lactams in critically ill patients with SARS-CoV-2 infection. Anaesth Crit Care Pain Med. 2020 06; 39(3):387-388.
-
Macrolide combination therapy for patients hospitalised with community-acquired pneumonia? An individualised approach supported by machine learning. Eur Respir J. 2019 12; 54(6).
-
Extended Infusion of ß-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study. Clin Infect Dis. 2019 10 30; 69(10):1731-1739.
-
SHV Hyperproduction as a Mechanism for Piperacillin-Tazobactam Resistance in Extended-Spectrum Cephalosporin-Susceptible Klebsiella pneumoniae. Microb Drug Resist. 2020 Apr; 26(4):334-340.
-
Impact of ß-Lactam and Daptomycin Combination Therapy on Clinical Outcomes in Methicillin-susceptible Staphylococcus aureus Bacteremia: A Propensity Score-matched Analysis. Clin Infect Dis. 2019 10 15; 69(9):1480-1488.